AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9349933 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous 6-mercaptopurine (1 g.m-2: bolus dose of 0.2 g.m-2 followed by an 8-h infusion of 0.8 g.m-2)
Number of subjects: 11
Study 9349933 — intervention group
Group type: COMPARATOR
Intervention: Oral 6-mercaptopurine (50-165 mg.m-2.day-1)
Number of subjects: 11
Study 8349376 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 30
Study 8349376 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 30
Study 8349376 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Nicardipine and Atenolol
Number of subjects: 30
Study 8349376 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 2427862 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiprolol 200 mg
Number of subjects: 18
Study 2427862 — intervention group
Group type: COMPARATOR
Intervention: Atenolol 100 mg
Number of subjects: 18
Study 2427862 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol 200 mg
Number of subjects: 18
Study 31112104 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramping protocol (first 1,000 shocks at energy level 5, followed by 1,000 shocks at energy level 6, and 1,000 final shocks at energy level 7)
Number of subjects: 300
Study 31112104 — intervention group
Group type: COMPARATOR
Intervention: Fixed voltage protocol (all 3,000 shocks at energy level 7)
Number of subjects: 300
Study 28706168 — intervention group
Group type: EXPERIMENTAL
Intervention: Violence Coping Program (VCP)
Number of subjects: 36
Study 28706168 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 36
Study 26445137 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill based visual cue training (T-VCT)
Number of subjects: 56
Study 26445137 — intervention group
Group type: EXPERIMENTAL
Intervention: Over-ground visual cue training (O-VCT)
Number of subjects: 56
Study 26445137 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 56
Study 23649799 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week exercise programme
Number of subjects: 46
Study 23649799 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study 21854552 — intervention group
Group type: EXPERIMENTAL
Intervention: Coblation tonsillectomy
Number of subjects: 80
Study 21854552 — intervention group
Group type: COMPARATOR
Intervention: Electrocautery tonsillectomy
Number of subjects: 80
Study 20183391 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-assisted emotional disclosure therapy
Number of subjects: 0
Study 16204287 — intervention group
Group type: EXPERIMENTAL
Intervention: Agalsidase alfa (0.2 mg/kg) infused intravenously every other week for 4-4.5 years
Number of subjects: 25
Study 15326238 — intervention group
Group type: COMPARATOR
Intervention: Normal Glucose (NG)
Number of subjects: 7027
Study 15326238 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired Fasting Glucose (IFG)
Number of subjects: 7027
Study 15326238 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 7027
Study 12555510 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftidrofuryl 200 mg tid
Number of subjects: 182
Study 12555510 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study 9404334 — intervention group
Group type: EXPERIMENTAL
Intervention: Variety Index for Toddlers (VIT)
Number of subjects: 124
Study 9404334 — intervention group
Group type: EXPERIMENTAL
Intervention: Bread group
Number of subjects: 124
Study 9404334 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable group
Number of subjects: 124
Study 9404334 — intervention group
Group type: EXPERIMENTAL
Intervention: Meat group
Number of subjects: 124
Study 9404334 — intervention group
Group type: EXPERIMENTAL
Intervention: VIT scores
Number of subjects: 124
Study 8099978 — intervention group
Group type: EXPERIMENTAL
Intervention: Timing principle group (vecuronium 0.15 mg.kg‐1 followed by thiopental 5 mg.kg‐1, intubation 60 seconds after thiopental)
Number of subjects: 40
Study 8099978 — intervention group
Group type: COMPARATOR
Intervention: SCC group (thiopental 5 mg.kg‐1 followed by SCC 1 mg.kg‐1 after loss of consciousness)
Number of subjects: 40
Study 3654234 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education program for children with asthma
Number of subjects: 239
Study 3654234 — intervention group
Group type: COMPARATOR
Intervention: Control group (no health education program)
Number of subjects: 239
Study 29767793 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined house dust and ozone exposure
Number of subjects: 23
Study 29767793 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone alone
Number of subjects: 23
Study 29767793 — intervention group
Group type: EXPERIMENTAL
Intervention: House dust alone
Number of subjects: 23
Study 27978834 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture at abdominal point ST 25
Number of subjects: 321
Study 27978834 — intervention group
Group type: COMPARATOR
Intervention: Park Sham at abdominal point ST 25
Number of subjects: 321
Study 27978834 — intervention group
Group type: COMPARATOR
Intervention: Needle + foam at abdominal point ST 25
Number of subjects: 321
Study 27978834 — intervention group
Group type: COMPARATOR
Intervention: Insertion and removal at abdominal point ST 25
Number of subjects: 321
Study 27978834 — intervention group
Group type: COMPARATOR
Intervention: Real + Park Sham at abdominal point ST 25
Number of subjects: 321
Study 27978834 — intervention group
Group type: COMPARATOR
Intervention: Real + needle and foam at abdominal point ST 25
Number of subjects: 321
Study 27978834 — intervention group
Group type: COMPARATOR
Intervention: Real + insertion and removal at abdominal point ST 25
Number of subjects: 321
Study 27978834 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture at lumbar point Bl 52
Number of subjects: 321
Study 27978834 — intervention group
Group type: COMPARATOR
Intervention: Park Sham at lumbar point Bl 52
Number of subjects: 321
Study 27978834 — intervention group
Group type: COMPARATOR
Intervention: Needle + foam at lumbar point Bl 52
Number of subjects: 321
Study 27978834 — intervention group
Group type: COMPARATOR
Intervention: Insertion and removal at lumbar point Bl 52
Number of subjects: 321
Study 27978834 — intervention group
Group type: COMPARATOR
Intervention: Real + Park Sham at lumbar point Bl 52
Number of subjects: 321
Study 27978834 — intervention group
Group type: COMPARATOR
Intervention: Real + needle and foam at lumbar point Bl 52
Number of subjects: 321
Study 27978834 — intervention group
Group type: COMPARATOR
Intervention: Real + insertion and removal at lumbar point Bl 52
Number of subjects: 321
Study 24113152 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 82
Study 24113152 — intervention group
Group type: COMPARATOR
Intervention: Sham TENS
Number of subjects: 82
Study 24113152 — intervention group
Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 82
Study 22591724 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of hyperpolarized (129)Xe gas mixed with (4)He gas (500 mL each)
Number of subjects: 33
Study 22591724 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of hyperpolarized (129)Xe gas
Number of subjects: 33
Study 20729301 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 1 measurement of total cholesterol
Number of subjects: 128
Study 20729301 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 1 measurement of triglycerides
Number of subjects: 128
Study 20729301 — intervention group
Group type: COMPARATOR
Intervention: Combined data from literature review
Number of subjects: 128
Study 18671864 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright blue light therapy (BLT)
Number of subjects: 126
Study 18671864 — intervention group
Group type: COMPARATOR
Intervention: Dim red light (placebo)
Number of subjects: 126
Study 15941372 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard trauma craniectomy (STC)
Number of subjects: 486
Study 15941372 — intervention group
Group type: COMPARATOR
Intervention: Limited craniectomy (LC)
Number of subjects: 486
Study 12150498 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg)
Number of subjects: 12
Study 12150498 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 12150498 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (suspected)
Number of subjects: 12
Study 12150498 — intervention group
Group type: COMPARATOR
Intervention: Placebo (suspected)
Number of subjects: 12
Study 10221556 — intervention group
Group type: EXPERIMENTAL
Intervention: Borderline patients
Number of subjects: 0
Study 10221556 — intervention group
Group type: COMPARATOR
Intervention: Acute and chronic schizophrenics
Number of subjects: 0
Study 10221556 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic schizophrenics
Number of subjects: 0
Study 10221556 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study 10221556 — intervention group
Group type: EXPERIMENTAL
Intervention: Discriminant analysis
Number of subjects: 0
Study 7602002 — intervention group
Group type: COMPARATOR
Intervention: Standard education protocol
Number of subjects: 42
Study 7602002 — intervention group
Group type: COMPARATOR
Intervention: Standard education and 30 minutes of verbal instruction
Number of subjects: 42
Study 7602002 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard education and a medication schedule
Number of subjects: 42
Study 7602002 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard education, a medication schedule, and 30 minutes of verbal instruction
Number of subjects: 42
Study 2225292 — intervention group
Group type: EXPERIMENTAL
Intervention: alfentanil 30 micrograms.kg‐1 (ALF 30)
Number of subjects: 60
Study 2225292 — intervention group
Group type: EXPERIMENTAL
Intervention: alfentanil 45 micrograms.kg‐1 (ALF 45)
Number of subjects: 60
Study 2225292 — intervention group
Group type: EXPERIMENTAL
Intervention: alfentanil 60 micrograms.kg‐1 (ALF 60)
Number of subjects: 60
Study 2225292 — intervention group
Group type: COMPARATOR
Intervention: normal saline (PLAC)
Number of subjects: 60
Study 27461 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine administered by aerosol route, three times a week for 5 weeks (Group I)
Number of subjects: 104
Study 27461 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group II)
Number of subjects: 104
Study 31756911 — intervention group
Group type: EXPERIMENTAL
Intervention: UltraRice Original (URO)
Number of subjects: 1950
Study 31756911 — intervention group
Group type: EXPERIMENTAL
Intervention: UltraRice New (URN)
Number of subjects: 1950
Study 31756911 — intervention group
Group type: EXPERIMENTAL
Intervention: NutriRice
Number of subjects: 1950
Study 31756911 — intervention group
Group type: COMPARATOR
Intervention: Unfortified rice (placebo)
Number of subjects: 1950
Study 27943546 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin (50 mg once-daily or twice-daily)
Number of subjects: 4996
Study 27943546 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4996
Study 25940724 — intervention group
Group type: EXPERIMENTAL
Intervention: O3-FAs 3.3 g daily for 24 weeks
Number of subjects: 249
Study 25940724 — intervention group
Group type: COMPARATOR
Intervention: Placebo (soybean/corn oil) daily for 24 weeks
Number of subjects: 249
Study 25940724 — intervention group
Group type: EXPERIMENTAL
Intervention: O3-FAs
Number of subjects: 249
Study 25940724 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 249
Study 25940724 — intervention group
Group type: EXPERIMENTAL
Intervention: O3-FAs and Placebo
Number of subjects: 249
Study 24015698 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of bioactive food ingredients (capsaicinoids, epigallocatechin gallate, piperin, and l-carnitine)
Number of subjects: 37
Study 24015698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 21988035 — intervention group
Group type: EXPERIMENTAL
Intervention: collodion‐Ten20
Number of subjects: 100
Study 21988035 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypafix‐Ten20
Number of subjects: 100
Study 21988035 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypafix‐Elefix
Number of subjects: 100
Study 19822394 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS of M1
Number of subjects: 52
Study 19822394 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS of DLPFC
Number of subjects: 52
Study 19822394 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 52
Study 19822394 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS of M1 or DLPFC
Number of subjects: 52
Study 17094387 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (somatostatin analog octreotide 20 mg i.m. every 28 days + oral dexamethasone 4 mg daily for 1 month, reduced to 1 mg daily by the fourth month, with a 1 mg daily maintenance dose thereafter + zoledronate 4 mg i.v. every 4 weeks)
Number of subjects: 38
Study 17094387 — intervention group
Group type: COMPARATOR
Intervention: Zoledronate only
Number of subjects: 38
Study 17094387 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 38
Study 15106005 — intervention group
Group type: EXPERIMENTAL
Intervention: Submaximal muscle actions at 20% increments from 20% to 80% peak torque (PT)
Number of subjects: 12
Study 15106005 — intervention group
Group type: EXPERIMENTAL
Intervention: Submaximal muscle actions
Number of subjects: 12
Study 11718252 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsillotomy using a CO2 laser
Number of subjects: 43
Study 11718252 — intervention group
Group type: COMPARATOR
Intervention: Standard tonsillectomy
Number of subjects: 43
Study 9703407 — intervention group
Group type: EXPERIMENTAL
Intervention: Tepoxalin 50 mg twice daily for 3.5 days
Number of subjects: 0
Study 9703407 — intervention group
Group type: EXPERIMENTAL
Intervention: Tepoxalin 200 mg twice daily for 3.5 days
Number of subjects: 0
Study 9703407 — intervention group
Group type: EXPERIMENTAL
Intervention: Tepoxalin (400 mg)
Number of subjects: 0
Study 8023548 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha with vaccine (20 micrograms Engerix-B + 1 million units of interferon-alpha)
Number of subjects: 176
Study 8023548 — intervention group
Group type: COMPARATOR
Intervention: Placebo with vaccine (20 micrograms Engerix-B + saline placebo)
Number of subjects: 176
Study 2685180 — intervention group
Group type: EXPERIMENTAL
Intervention: Histopathologic peer review
Number of subjects: 240
Study 2685180 — intervention group
Group type: EXPERIMENTAL
Intervention: Grading highly malignant soft tissue sarcoma in two grades (III and IV)
Number of subjects: 240
Study 2685180 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy multicenter trial
Number of subjects: 240
Study 803830 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridinol carbamate
Number of subjects: 23
Study 803830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 30732996 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose ferrous sulfate (1-3 mg/kg/day)
Number of subjects: 0
Study 30732996 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Lactobacillus plantarum 299v (LP299v)
Number of subjects: 0
Study 30732996 — intervention group
Group type: COMPARATOR
Intervention: Control (no probiotic)
Number of subjects: 0
Study 29078256 — intervention group
Group type: EXPERIMENTAL
Intervention: High sensitivity C-reactive protein (hsCRP) levels at randomization (22-34 weeks)
Number of subjects: 100
Study 29078256 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin levels at randomization (22-34 weeks)
Number of subjects: 100
Study 27580595 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEpo (24,000 IU, 3 intravenous doses)
Number of subjects: 36
Study 27580595 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 27580595 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEpo
Number of subjects: 36
Study 27580595 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of operation
Number of subjects: 36
Study 23793486 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based data collection
Number of subjects: 0
Study 23793486 — intervention group
Group type: COMPARATOR
Intervention: Telephone data collection
Number of subjects: 0
Study 23793486 — intervention group
Group type: COMPARATOR
Intervention: Self-administered (mailed) questionnaires
Number of subjects: 0
Study 21711467 — intervention group
Group type: EXPERIMENTAL
Intervention: 308-nm xenon chloride excimer laser (EL)
Number of subjects: 14
Study 21711467 — intervention group
Group type: COMPARATOR
Intervention: Narrow-band ultraviolet B (NB-UVB)
Number of subjects: 14
Study 20821281 — intervention group
Group type: EXPERIMENTAL
Intervention: 23 gauge needle
Number of subjects: 155
Study 20821281 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 gauge needle
Number of subjects: 155
Study 17673038 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss (diet and exercise)
Number of subjects: 106
Study 17673038 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss and metformin (500 mg three times daily)
Number of subjects: 106
Study 17673038 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss and rosiglitazone (4 mg once daily)
Number of subjects: 106
Study 17673038 — intervention group
Group type: COMPARATOR
Intervention: Weight loss
Number of subjects: 106
Study 15672210 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene treatment
Number of subjects: 0
Study 12001016 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral load of 300 ml of magnesium-rich mineral water (1.2 mmol Mg)
Number of subjects: 10
Study 12001016 — intervention group
Group type: COMPARATOR
Intervention: Intravenous injection of (28)Mg
Number of subjects: 10
Study 10048795 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Protein (HP) treatment
Number of subjects: 16
Study 10048795 — intervention group
Group type: EXPERIMENTAL
Intervention: Equal mixture (M) treatment (33% protein)
Number of subjects: 16
Study 10048795 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Fat (HF) treatment
Number of subjects: 16
Study 10048795 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Carbohydrate (HC) treatment
Number of subjects: 16
Study 9395624 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-hypnosis relaxation techniques taught the night prior to surgery
Number of subjects: 0
Study 9395624 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0
Study 1919343 — intervention group
Group type: EXPERIMENTAL
Intervention: Permucosal needle aspiration
Number of subjects: 60
Study 1919343 — intervention group
Group type: COMPARATOR
Intervention: Incision and drainage
Number of subjects: 60
Study 1919343 — intervention group
Group type: EXPERIMENTAL
Intervention: Admission to hospital and treatment with intravenous antibiotics
Number of subjects: 60
Study 1919343 — intervention group
Group type: EXPERIMENTAL
Intervention: Culture of pus
Number of subjects: 60
Study 6797782 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-estradiol contraceptive vaginal rings (2 sizes)
Number of subjects: 1500
Study 6797782 — intervention group
Group type: COMPARATOR
Intervention: Nordette (oral contraceptive)
Number of subjects: 1500
Study 6360689 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 74
Study 6360689 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 31335267 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative message
Number of subjects: 467
Study 31335267 — intervention group
Group type: COMPARATOR
Intervention: Nonnarrative message
Number of subjects: 467
Study 29140444 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-2 doses of bivalent virus-like particle (VLP) norovirus vaccine candidate formulations
Number of subjects: 420
Study 29140444 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-2 doses of 15 μg GI.1/50 μg GII.4c formulation
Number of subjects: 420
Study 29140444 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular control vaccine (hepatitis A)
Number of subjects: 420
Study 26562363 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (low dose: target plasma concentration of 0.2 ng/ml)
Number of subjects: 6
Study 26562363 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (high dose: target plasma concentration of 0.6 ng/ml)
Number of subjects: 6
Study 26562363 — intervention group
Group type: COMPARATOR
Intervention: Control PET scan (no dexmedetomidine)
Number of subjects: 6
Study 24768130 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation (CR)
Number of subjects: 85
Study 24768130 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 85
Study 22260823 — intervention group
Group type: EXPERIMENTAL
Intervention: Rikkunshito
Number of subjects: 27
Study 22260823 — intervention group
Group type: COMPARATOR
Intervention: Domperidone
Number of subjects: 27
Study 19709893 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural blockade (TEB)
Number of subjects: 44
Study 19709893 — intervention group
Group type: COMPARATOR
Intervention: Paravertebral blockade (PVB)
Number of subjects: 44
Study 17401007 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal methotrexate with intravenous high-dose methotrexate (1 g/m2)
Number of subjects: 456
Study 17401007 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal methotrexate with 18 Gy cranial radiation
Number of subjects: 456
Study 17401007 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal methotrexate with 24 Gy cranial radiation
Number of subjects: 456
Study 16267721 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin
Number of subjects: 0
Study 12943879 — intervention group
Group type: EXPERIMENTAL
Intervention: History of peripheral vascular disease
Number of subjects: 0
Study 12943879 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 0
Study 10609695 — intervention group
Group type: EXPERIMENTAL
Intervention: Rating scale for post-stroke psychiatric symptoms
Number of subjects: 30
Study 10609695 — intervention group
Group type: EXPERIMENTAL
Intervention: Global Change Scale (GCS)
Number of subjects: 30
Study 8946434 — intervention group
Group type: COMPARATOR
Intervention: d-fenfluramine HCl 0.5 mg/kg
Number of subjects: 11
Study 8946434 — intervention group
Group type: COMPARATOR
Intervention: d-fenfluramine HCl 1.0 mg/kg
Number of subjects: 11
Study 8946434 — intervention group
Group type: COMPARATOR
Intervention: d,l-fenfluramine HCl 1.0 mg/kg
Number of subjects: 11